Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study (ETHICHS)

Clinical trial NCT03743103 · TERMINATED

Trial details

NCT number: NCT03743103
Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Hemorrhagic Stroke

Start date: 2019-04-18
Primary completion: 2021-10-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.